DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment

BACKGROUND: With the success of poly(ADP-ribose) polymerase (PARP) inhibitor therapy in the first-line and second-line treatment settings, a new patient population is emerging with platinum-sensitive relapsed ovarian cancer, who have previously received a PARP inhibitor in the maintenance setting an...

Descripción completa

Detalles Bibliográficos
Autores principales: McMullen, Michelle, Karakasis, Katherine, Loembe, Bienvenu, Dean, Emma, Parr, Graem, Oza, Amit M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656147/
https://www.ncbi.nlm.nih.gov/pubmed/32878963
http://dx.doi.org/10.1136/ijgc-2020-001694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656147/
https://www.ncbi.nlm.nih.gov/pubmed/32878963
http://dx.doi.org/10.1136/ijgc-2020-001694

Ejemplares similares